The University Of Texas Health Science Center, Houston
Clinical trials sponsored by The University Of Texas Health Science Center, Houston, explained in plain language.
-
New program aims to stop opioid misuse in hispanic teens before it starts
Prevention TerminatedThis study tested educational videos for Hispanic/Latinx families with teens aged 15-17 to prevent opioid misuse and overdose. The program focused on safe storage, opioid knowledge, and changing attitudes. Only 6 families took part before the study ended early.
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 15, 2026 19:05 UTC
-
Warming blankets during C-Sections: a small study that fizzled out
Symptom relief TerminatedThis study tested different ways to keep women warm during planned C-sections, such as using forced air warming blankets and warmed IV fluids. The goal was to see which method best prevents hypothermia (low body temperature) in the mother and newborn. The trial was stopped early …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 23, 2026 11:56 UTC
-
Hand massage for brain injury? small study tests fluid drainage and thinking
Symptom relief TerminatedThis study looked at whether a daily 5-day course of manual lymphatic drainage (a type of gentle massage) could improve fluid drainage from the brain and help thinking skills in people with moderate to severe traumatic brain injury. Only 2 people were enrolled before the study wa…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 22, 2026 12:07 UTC
-
Sleep study for baby hemangioma drug stopped early
Symptom relief TerminatedThis study looked at whether giving propranolol two or three times a day affects sleep in infants with hemangiomas (benign blood vessel growths). It enrolled 52 infants and compared sleep awakenings and total awake time at night. The study was terminated early, so findings are li…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 22, 2026 11:59 UTC
-
New combo therapy for smokers with schizophrenia: early hints, big questions
Symptom relief TerminatedThis small pilot study tested whether a combination of an injectable drug (naltrexone) and an oral drug (bupropion) is safe and feasible for helping people with schizophrenia quit smoking. Only 2 participants were enrolled before the study was terminated. The goal was to see if t…
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 22, 2026 11:57 UTC